Abstract
BackgroundEngineered exosomes are emerging as a novel therapeutic modality for cancer immunotherapy. Leveraging cell type specific delivery, tumor restricted pharmacology and compartmental dosing, exosome-based immunotherapy can elicit a tumor specific...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have